While it is not a treatment for hair loss, it may help improve the visible quality of the scalp and support the appearance of thicker, healthier-looking hair
The more relevant distinction is how the dosing was studied and what outcomes it was designed to support
EPA is also a cyclooxygenase substrate for the biosynthesis of PGE3 which also exert inflammatory activity, albeit PGE3 biosynthesis occurs with very low efficiency [5]
Because it activates both, it's often called a "dual agonist." The FDA has described tirzepatide (brand name Zepbound) as the first medication of its kind to activate both of these receptors for weight management, and it was approved for that use in November 2023
During the session, you can relax, read, or use your phone while your body absorbs essential vitamins, minerals, and fluids
Semaglutide is highly effective, tirzepatide is superior with dual agonism, and retatrutide, with its triple-action mechanism, currently offers the greatest weight loss and best tolerability seen in pharmacotherapy